Fibromyalgia drug sparks debate

Jan 14, 2008

Pfizer heralded the effectiveness of its newly approved fibromyalgia treatment, Lyrica, as some U.S. doctors question the very existence of the condition.

Lyrica acts as a central nervous system depressant that alleviates some painful conditions associated with fibromyalgia but some doctors, including Dr. Frederick Wolfe who first described the diagnostic guidelines for the condition, say it isn't a disease, The New York Times said Monday.

Fibromyalgia primarily affects middle-age woman and is associated with chronic and pervasive pain of unknown origin. Most sufferers don't respond to painkillers such as aspirin or narcotic analgesics such as codeine.

Many doctors fear the emergence of Lyrica as a treatment will validate the contentious diagnosis and may actually worsen the symptoms by persuading sufferers from obsessing over aches and pains other people may tolerate, the Times said.

Wolfe, director of the National Databank for Rheumatic Diseases, told the Times he considered the condition a psychosomatic response to emotional trauma.

The American College of Rheumatology, the Food and Drug Administration and health insurers recognize fibromyalgia as a diagnosable disease.

Critics and opponents, however, agree that Lyrica treats patients who don't respond to conventional pain killers.

Copyright 2008 by United Press International

Explore further: Drug research and development more efficient than expected

add to favorites email to friend print save as pdf

Related Stories

Google hits back at rivals with futuristic HQ plan

19 hours ago

Google unveiled plans Friday for a new campus headquarters integrating wildlife and sweeping waterways, aiming to make a big statement in Silicon Valley—which is already seeing ambitious projects from Apple ...

Recommended for you

Drug research and development more efficient than expected

23 hours ago

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

eadoran
5 / 5 (1) Jan 14, 2008
Contrary to Wolfe's opinion that Fibromyalgia is pychosomatic, I contracted it following a virus four years ago. There have been noted many other triggers for this condition to occur.

Considering he wrote the diagnostic criteria for fibromyaliga, this is a rather insulting turn around to sufferers of this very real and very painful condition.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.